US20060058743A1 - Depth probe for intracranial treatment - Google Patents
Depth probe for intracranial treatment Download PDFInfo
- Publication number
- US20060058743A1 US20060058743A1 US11/262,377 US26237705A US2006058743A1 US 20060058743 A1 US20060058743 A1 US 20060058743A1 US 26237705 A US26237705 A US 26237705A US 2006058743 A1 US2006058743 A1 US 2006058743A1
- Authority
- US
- United States
- Prior art keywords
- depth probe
- proximal
- brain
- probe
- depth
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/03—Detecting, measuring or recording fluid pressure within the body other than blood pressure, e.g. cerebral pressure; Measuring pressure in body tissues or organs
- A61B5/031—Intracranial pressure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
- A61B5/6846—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive
- A61B5/6847—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive mounted on an invasive device
- A61B5/6852—Catheters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/1468—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using chemical or electrochemical methods, e.g. by polarographic means
- A61B5/1473—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using chemical or electrochemical methods, e.g. by polarographic means invasive, e.g. introduced into the body by a catheter
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/40—Detecting, measuring or recording for evaluating the nervous system
- A61B5/4076—Diagnosing or monitoring particular conditions of the nervous system
- A61B5/4094—Diagnosing or monitoring seizure diseases, e.g. epilepsy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/10—Balloon catheters
- A61M2025/1043—Balloon catheters with special features or adapted for special applications
- A61M2025/105—Balloon catheters with special features or adapted for special applications having a balloon suitable for drug delivery, e.g. by using holes for delivery, drug coating or membranes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/10—Balloon catheters
- A61M2025/1043—Balloon catheters with special features or adapted for special applications
- A61M2025/1052—Balloon catheters with special features or adapted for special applications for temporarily occluding a vessel for isolating a sector
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2210/00—Anatomical parts of the body
- A61M2210/06—Head
- A61M2210/0693—Brain, cerebrum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/0067—Catheters; Hollow probes characterised by the distal end, e.g. tips
- A61M25/0068—Static characteristics of the catheter tip, e.g. shape, atraumatic tip, curved tip or tip structure
- A61M25/007—Side holes, e.g. their profiles or arrangements; Provisions to keep side holes unblocked
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/01—Introducing, guiding, advancing, emplacing or holding catheters
- A61M25/06—Body-piercing guide needles or the like
- A61M25/0662—Guide tubes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/10—Balloon catheters
Definitions
- the present invention relates to instrumentation utilized for intracranial treatment and, in particular, to depth probes utilized for intracranial treatment.
- Movement disorders such as epilepsy and Parkinson's disease have been estimated to affect some 1-2% of the developed world's population and up to 10% of people in underdeveloped countries. Currently, approximately 75% of those who suffer from movement disorders are responsive in some degree to drugs.
- Depth electrodes can be placed within the brain tissue itself, enabling optimal surface contact with elements of the brain that are targeted for stimulation. This allowed for safe, chronic electrical stimulation of very small discrete volumes of brain.
- Electrodes have been used to obtain signals representative of current brain activity along with a signal processor for continuous monitoring and analysis of these electrical signals in order to identify important changes or the appearance of precursors predictive of an impending change.
- Improved intracranial monitoring devices have been shown to facilitate treatments of movement disorders. Monitoring is typically performed by instruments which are inserted into the brain at different locations or along different tracks. Other systems employ a single device which must be removed and reinserted to provide for delivery of multiple drugs or use of different electrical devices.
- probes or other similar devices into the brain is common in many surgical procedures today, there are a variety of probes available.
- probes typically include ports for drug delivery or electrical, chemical, electrochemical, temperature and/or pressure contacts which enable the observation and analysis of the brain state or contacts providing stimulation. These ports and contacts must typically be positioned at specific points or regions in the brain.
- Probes used in intracranial penetration are typically fabricated so that their introduction to the brain is as minimally traumatic as possible.
- certain inserted probes must also be able to remain implanted without causing injury through unintended movement.
- a probe may be implanted and remain in the patient's brain for weeks or longer. Changes in the positioning of the probe often occur during placement or during such extended periods. Therefore, the probe must be capable of precise placement and as bio-compatible as possible.
- state of the art intracranial probes are typically thin, flexible pieces with smooth surfaces to minimize the amount of brain tissue contacted and to minimize damage to contacted brain tissue.
- Another object of the invention is to provide a novel depth probe that is simple in structure and operation in order to facilitate intracranial procedures.
- Another object of the invention is to provide an exceptional depth probe having a body adapted to avoid extensive trauma to and scarring of brain tissue.
- Another object of the invention is to provide an excellent depth probe having a body that includes contacts for stimulation and/or for monitoring of the brain.
- Another object of the invention is to provide a desirable depth probe having a lumen for receiving and guiding an inner catheter for the delivery of a drug to targeted brain tissue and that can remain in position when the inner catheter is removed, thereby permitting repeated insertions of different inner catheters without extended contact with brain tissue during insertion.
- Another object of the invention is to provide an exceptional depth probe that provides an attached connector conductively connected to a plurality of monitoring and sensing elements for efficient and effective transmission of readings from the elements to external analysis and control devices.
- Yet another object of the invention is to provide a novel depth probe having a distal portion provided with an inflatable balloon capable of sealing off the insertion tract formed by the probe to prevent a drug being introduced into the brain by the probe from migrating back through the tract and further allows for the monitoring of cellular function within the brain prior to and after introduction of the drug.
- the invention is for a depth probe utilized to provide intracranial treatment of a patient.
- the depth probe comprises a body having a distal portion with at least one aperture and at least one element, a lumen defined by the body that communicates between an opening and the aperture, and a proximal portion with at least one proximal-contact.
- the proximal-contact is conductively connected with the element.
- conductively connected is meant to include a connection via a lead in the form of a wire or fiber-optic bundle for the transmission of electrical and/or optical signals.
- a number of highly preferred embodiments have the lumen sized to receive an inner catheter adapted to transfer a fluid with a tissue region within the patient's brain.
- the body is made from substantially inflexible material.
- One preferred embodiment finds the opening on the body having a tapered fitting so that a pumping instrument can be connected to the probe at the fitting for the transfer of a fluid with a tissue region of the patient's brain.
- the opening is at the proximal end of the body and coaxial with the lumen.
- the aperture is in axial alignment with the lumen.
- the distal end of the probe is closed and the aperture is spaced away from the distal end along the distal portion. More desirable is where the body has at least first and second apertures in communication with the lumen, each aperture being spaced axially along the distal portion. Highly desirable is where the probe has first and second apertures communicating with the lumen that are spaced radially about the body's axis along the distal portion.
- the element is a contact that can provide electrical stimulation to tissue regions within the patient's brain. Also desirable is where the element is a contact that monitors activity, preferably electrical activity, within the patient's brain. More desirable is where the probe has a plurality of contacts spaced axially along its distal portion, each of these contacts being a macro-contact that collars, i.e., circumscribes, the body. Highly desirable is where the contact is a micro-contact and preferably where the probe has a plurality of micro-contacts spaced axially and radially along its distal portion.
- Another appreciated embodiment finds the element to be a sensor. Much preferred is where the sensor senses chemical activity within the brain. Another element found desirable is where it is a location marker that allows the position of the distal portion of the probe to be identified when it is inserted into the brain. This embodiment is especially desirable when the marker is adapted to be identified, i.e. seen, under magnetic resonance imaging.
- One very preferred example of this invention is where there are a plurality of proximal-contacts and a connector adapted to receive these proximal-contacts is secured to the body. It is desirable that each of these proximal-contacts be in electrical communication with a micro-contact. More desirable is where the connector extends outward from the body and has a housing formed to position the proximal-contacts in a linear array. The connector in this embodiment has a lead-conduit extending from this housing that connects it to the body of the probe. A highly preferred embodiment finds the connector as being firmly attached to the body.
- proximal portion of the body has a first diameter and its distal portion has a second diameter such that the second diameter is less than the first diameter.
- a depth probe comprising a body having a distal portion with at least one aperture and one element, a lumen defined by the body that communicates between an opening and the aperture, and a conduit extending from its proximal portion to an inflatable balloon secured upon its distal portion.
- the balloon is inflatable with at least one drug and the balloon is formed from a material permeable to this drug so that the drug can be introduced into the tissue region through the balloon.
- the balloon is adapted to seal upon inflation the tract created by the probe upon its insertion into the brain.
- a most desirable embodiment has the balloon positioned along the distal portion of the body at a point proximal to the aperture. Highly preferred is where the balloon is positioned along the distal portion and is also proximal to the element on the probe.
- this probe also includes at least one proximal-contact along a proximal portion at its proximal end.
- the proximal-contact is conductively connected with the element through a lead.
- FIG. 1 is a perspective view of a preferred depth probe having a connector extending outward from the body in accordance with this invention with cut-away sections to reveal and dashed lines to represent otherwise unseen internal features.
- FIGS. 2A and 2B are perspective views of the distal portions of alternate preferred depth probes in accordance with this invention with dashed lines to represent otherwise unseen internal features.
- FIG. 3 is a perspective view of another preferred depth probe in accordance with this invention receiving an inner catheter with cut-away sections to reveal and dashed lines to represent otherwise unseen internal features.
- FIG. 4 is a perspective view of an alternate embodiment of the depth probe having a connector attached to the body in accordance with this invention with a cut-away section.
- FIG. 5A is a perspective view of a preferred depth probe having a balloon shown deflated in accordance with this invention with cut-away sections to reveal and dashed lines to represent otherwise unseen internal features.
- FIG. 5B is the distal end of the depth probe of FIG. 5A showing the balloon inflated with cut-away sections to reveal and dashed lines to represent otherwise unseen internal features.
- FIG. 6 is a schematic view illustrating the depth probe of FIGS. 5A and 5B positioned within the brain.
- FIG. 1 is a perspective view of depth probe 10 having an elongated, tubular body 12 extending from proximal end 14 to distal end 16 .
- Body 12 preferably has a diameter between about 0.6 and 3.0 millimeters, most preferably about 1.0 millimeter.
- body 12 includes elements 18 secured to distal portion 20 at distal end 16 .
- Body 12 is also provided with lumen 22 extending from opening 24 at proximal end 14 and in communication with aperture 26 .
- Lumen 22 is a tubular channel extending for some length within body 12 , preferably having a diameter of 0.5 millimeters or less.
- Body 12 is open at distal end 16 to form aperture 26 . Opening 24 and aperture 26 are coaxial with lumen 22 along central axis 28 of body 12 .
- Elements 18 are conductively connected by leads 30 (seen in FIG. 1 running alongside lumen 22 ) to proximal-contacts 32 .
- Leads 30 can be in the form of electrical wiring or a fiber-optic bundle.
- Proximal-contacts 32 are mounted along proximal portion 34 of body 12 . When depth probe 10 is inserted into the brain, proximal-contacts 32 remain outside of the patient.
- Proximal-contacts 32 are preferably formed from stainless steel or similar alloys or materials that are non-corrosive conductors and that can endure sterilization.
- Depth probe 10 can be substantially flexible, formed from bio-compatible materials such as polyurethane, silicone, or polyimide.
- Body 12 can also be in the form of a cannula where body 12 is made from a substantially rigid material that is preferably MRI safe/compatible.
- Such preferable materials are platinum, titanium, polyimide-coated glass, and other non-ferrous alloys.
- depth probe 10 may be used with a stereotatic frame or a frameless guidance system to accurately position the catheter within the brain.
- preferred embodiments of depth probe 10 can have a closed distal end 16 and a plurality of apertures 26 , each aperture 26 in communication with lumen 22 .
- Apertures 26 in FIG. 2A are positioned above distal end 16 and spaced in axial alignment with axis 28 along distal portion 20 .
- Apertures 26 in FIG. 2B are shown axially and radially spaced about axis 28 .
- these configurations can also include an aperture 26 forming an open distal end 16 as depicted in FIG. 1 .
- Body 12 of depth probe 10 may also include a distal portion 20 having a reduced diameter as illustrated in FIG. 3 .
- Such a configuration for distal portion 20 allows for reduced injury to the surrounding tissue regions during the insertion of depth probe 10 into the brain.
- lumen 22 is preferably sized so as to be able to receive an inner catheter 36 , i.e., lumen 22 is provided with a diameter slightly greater than the outside diameter of inner catheter 36 .
- inner catheter 36 can be inserted into opening 24 and guided by lumen 22 to this tissue area.
- Inner catheter 36 can be withdrawn and reinserted or different inner catheters 36 can be inserted into depth probe 10 without reinserting or repositioning depth probe 10 .
- Inner catheter 36 is preferably polyimide, polyimide-coated glass or other similar material. Applicant notes that one such preferred catheter is disclosed in U.S.
- Proximal end 14 of body 12 is provided with a tapered fitting 38 , preferably a male luer conical fitting, to provide for a detachable fluid-tight coupling with some external device.
- the proximal end of inner catheter 36 is provided with a tapered coupler 40 , preferably a luer coupler that has female luer fittings at both of its ends.
- Tapered coupler 40 enables inner catheter 36 to form a liquid-tight joint with depth probe 10 when inner catheter 36 is fully inserted into lumen 22 through opening 24 .
- Coupler 40 enables inner catheter 36 to be operatively connected by tubing to an external piece of equipment such as a pump.
- inner catheter 36 could also be connected to internal instrumentation having pumping capability. This process enables fluids such as drugs to be administered to the brain through inner catheter 36 .
- Elements 18 provide for monitoring of brain activity, for stimulating brain tissue or for serving as a location beacon to aid in determining the precise position of distal portion 20 within the brain.
- Elements 18 can take the form of contacts 42 , as illustrated in FIGS. 1-6 .
- Contacts 42 comprise devices such as electrodes 44 designed to monitor brain activity in a selected tissue region of the brain 46 through the sensing of electrical and/or electrochemical changes within the brain as well as electrodes 48 designed to provide electrical stimulation to specific areas of the brain.
- Electrodes serving as contacts 42 are preferably constructed from platinum, platinum-iridium or other bio-compatible conductive material. Electrodes can be macro-contacts 49 that circumscribe or band body 12 or micro-contacts 50 capable of measuring electrical changes at the level of a single neuron.
- Elements 18 can also can take the form of a sensor 52 as depicted in FIG. 3 .
- Sensors 52 are designed to monitor brain activity within select tissue regions through the sensing of electrical, electrochemical, chemical, temperature or pressure changes within the brain.
- Sensors 52 can be electrochemical and optical transducers designed to measure chemical, pressure, temperature, cerebral blood flow and other physiological changes in the brain. Such devices are known in the art and are preferably less than about 2 millimeters long.
- Sensor 52 is preferably in the form of a chemical sensor.
- Elements 18 may further be in the form of a location marker 54 as seen in FIGS. 5A and 5B .
- Location marker 54 is preferably a structure comprised of a non-ferrous material known in the art such as gold or tungsten that has an image signal intensity suitable for proton magnetic resonance imaging (MRI) with most commercial machines and is also sufficiently x-ray opaque for satisfactory imaging using computed tomographic scanning (CT) or on X-ray.
- Location marker 54 can also be comprised of a sensor capable of measuring voltages induced by a transmitted magnetic field that can be used to identify the position and orientation of the sensor within that field.
- Elements 18 may be positioned on both the distal and proximal sides of apertures 26 along distal portion 20 as seen in FIGS. 2A and 2B .
- This configuration allows for monitoring of cellular function within the tissue region of the brain 46 being targeted prior to treatment to verify the presence of diseased brain cells.
- delivery of a drug or other treatment agent can commence through depth probe 10 while monitoring of the tissue region 46 continues concurrently with such treatment. This can have particular value in the treatment of different tissue regions of the brain for movement disorders such as Parkinson's Disease.
- FIGS. 1, 2 , 5 A and 5 B show that macro-contacts 49 are spaced axially along distal portion 20 .
- Micro-contacts 50 can be spaced axially along distal portion 20 as illustrated in FIG. 4 or spaced radially around body 12 as shown in FIG. 1 .
- FIGS. 5A and 5B illustrate a depth probe 10 having an inflatable balloon 56 rigidly mounted to distal portion 20 , preferably above at least one element 18 and at least one aperture 26 .
- a conduit 58 enters body 12 along proximal portion 34 and runs alongside lumen 22 , terminating at balloon 56 .
- Conduit 58 is preferably tubing made of polyurethane.
- Conduit 58 provides for the introduction of a fluid to inflate balloon 56 and, if necessary to withdraw fluid from balloon 56 to cause deflation.
- Conduit 58 originates at injection port 60 that can be operatively connected to an external device 62 such as a pump to dispense or receive fluid.
- balloon 56 can be inflated to block or occlude the insertion tract 64 created during the insertion process so that any drug administered to the brain 46 through aperture 26 cannot migrate back through that tract.
- Balloon 56 is preferably made from an elastomeric material to achieve complete deflation of balloon 56 when depth probe 10 is later withdrawn from the brain.
- balloon 56 is permeable. Balloon 56 in these embodiments can be inflated with a drug or other fluid intended to be administered to the brain whereby the drug then permeates through the wall of balloon 56 to treat the tissue region of the brain 46 surrounding balloon 56 . In this manner, a drug can be introduced to one targeted tissue region of the brain delivered by depth probe 10 through aperture 26 at the same time the same or a different drug is transferred to another selected tissue region through permeable balloon 56 . Balloon 56 is preferably adapted to administering a drug to the brain slowly over a period of time, thereby allowing for the effective introduction of the drug to the desired tissue region. This is especially desirable where there is a void in the particular tissue region due to some structure such as a tumor being removed. Inflating balloon 56 within the void permits the medication to be more effectively transferred to all of the affected tissue that surrounds the outside of the balloon.
- balloon 56 can be made permeable by forming balloon 56 from a naturally porous material such as polytetrafluroethylene (PTFE) or from an elastomeric material having perforations formed in the wall of the balloon.
- the balloon wall is preferably from 0.5 to 5.0 mils in thickness.
- an array of minute perforations, each having a diameter of 5 to 30 microns, is preferably uniformly spaced apart and concentrated along a central band circumscribing balloon 56 . Concentration of the perforations within such a region in the middle of balloon 56 provides for focused delivery of the drug by limiting the area of permeation to just the surface area of balloon 56 making conforming contact with the surrounding brain tissue.
- Tapered fitting 38 enables depth probe 10 , as shown in FIG. 6 , to form a liquid-tight seal with tubing or similar conduit having a female luer connector.
- opening 24 of body 12 is operatively connected by the tubing to an external instrument such as pumping equipment 66 .
- pumping equipment 66 One skilled in the art will recognize that depth probe 10 could also be connected to internal instrumentation having pumping capability.
- Such equipment allows fluids to be transferred to or from tissue region of the brain 46 through any aperture 26 . Drugs can then be administered to the brain, cerebral spinal fluid can be withdrawn, or both.
- Depth probe 10 can also include a connector 68 .
- Connector 68 comprises a housing 69 mounting a linear array 70 of proximal-contacts.
- Connector 68 is conductively connected via additional leads 30 to elements 18 , preferably micro-contacts 50 , along distal portion 20 .
- Connector 68 can be rigidly mounted to body 12 along its proximal portion 34 as shown in FIG. 4 .
- Connector 68 can also extend outward from body 12 as seen in FIG. 1 .
- Connector 68 in this embodiment is secured to body 12 by lead-conduit 72 .
- Leads 30 that originate at connector 68 pass through lead-conduit 72 before entering body 12 at a point along proximate portion 34 to proceed along lumen 22 to the corresponding elements 18 .
- proximal-contacts 32 are in an axial alignment that adapts them to being conductively connected to an external connector (not shown) in operative communication with a computer or similar instrument having a conventional output display and monitor with a suitable power source. This enables the brain activity sensed by elements 18 linked to these proximal-contacts to be recorded and/or analyzed and/or control over elements 18 to be exercised.
Abstract
A depth probe for intracranial treatment is provided having a body that includes a distal portion with at least one aperture and at least one element, a lumen defined by the body that communicates between an opening and the aperture, and a proximal portion with at least one proximal-contact. The proximal-contact is conductively connected with the element. The lumen is preferably sized to receive an inner catheter adapted to transfer a fluid such as a drug with a tissue region within the patient's brain. The depth probe can include a connector adapted to receive a plurality of proximal-contacts. A depth probe is disclosed that has a distal portion with an aperture and element, a lumen communicating between an opening and the aperture, and an inflatable balloon secured upon its distal portion. The balloon is adapted to seal upon inflation the tract created by the probe when inserted into the brain.
Description
- This application claims the benefit of U.S. patent application Ser. No. 10/423,587, filed on Apr. 25, 2003.
- The present invention relates to instrumentation utilized for intracranial treatment and, in particular, to depth probes utilized for intracranial treatment.
- Movement disorders such as epilepsy and Parkinson's disease have been estimated to affect some 1-2% of the developed world's population and up to 10% of people in underdeveloped countries. Currently, approximately 75% of those who suffer from movement disorders are responsive in some degree to drugs.
- Electrical stimulation has also been utilized to treat some movement disorders. In the treatment of epilepsy, studies have been performed in which awake patients undergoing temporal lobe surgery underwent cortical stimulation. Such stimulation of the visual and hearing areas of the brain reproducibly caused the patients to experience visual and auditory phenomena. This discovery was made possible by the identification that certain brain subregions served specific functions, such as sight, hearing, touch and movement of the extremities and proved that direct electrical stimulation of the brain regions could cause partial reproduction or suppression of the functions.
- As suggested by these results, it is known that certain types of treatment of specific portions of the brain are able to suppress certain unwanted behavior which results from movement disorders. This behavior may include seizures such as those suffered by epileptics. However, the studies faced a major problem in that there was an inability to precisely electrically stimulate very small volumes of the brain.
- The advent of needle-shaped penetrating depth electrodes helped to overcome this obstacle faced by electrical stimulation. Depth electrodes can be placed within the brain tissue itself, enabling optimal surface contact with elements of the brain that are targeted for stimulation. This allowed for safe, chronic electrical stimulation of very small discrete volumes of brain.
- In treatment, electrical stimulation has been used with the recording and analysis of changes in brain activity to predict the occurrence of epileptic seizures. The time of onset of such seizures is often predictable by neural discharge monitoring, even when the exact causal nature of precipitating dysfunction is not understood. Electrodes have been used to obtain signals representative of current brain activity along with a signal processor for continuous monitoring and analysis of these electrical signals in order to identify important changes or the appearance of precursors predictive of an impending change.
- While the electrical stimulation of brain tissue has been somewhat effective in the treatment of migraines, epilepsy and other neurological problems, patients often experience diminishing returns with such treatment. Furthermore, because each patient reacts differently to electrical stimulation, substantial time must be spent to determine the specific amplitude, frequency, pulse width, stimulation duration, etc. which may result in effective treatment. In addition, such parameters often require continual adjustment in order to remain effective.
- Improved intracranial monitoring devices have been shown to facilitate treatments of movement disorders. Monitoring is typically performed by instruments which are inserted into the brain at different locations or along different tracks. Other systems employ a single device which must be removed and reinserted to provide for delivery of multiple drugs or use of different electrical devices.
- Since the introduction of probes or other similar devices into the brain is common in many surgical procedures today, there are a variety of probes available. Such probes typically include ports for drug delivery or electrical, chemical, electrochemical, temperature and/or pressure contacts which enable the observation and analysis of the brain state or contacts providing stimulation. These ports and contacts must typically be positioned at specific points or regions in the brain.
- Probes used in intracranial penetration are typically fabricated so that their introduction to the brain is as minimally traumatic as possible. In addition to being minimally traumatic during insertion, certain inserted probes must also be able to remain implanted without causing injury through unintended movement. In some uses, a probe may be implanted and remain in the patient's brain for weeks or longer. Changes in the positioning of the probe often occur during placement or during such extended periods. Therefore, the probe must be capable of precise placement and as bio-compatible as possible. In response to these requirements, state of the art intracranial probes are typically thin, flexible pieces with smooth surfaces to minimize the amount of brain tissue contacted and to minimize damage to contacted brain tissue.
- While such thin, flexible probes are sufficiently bio-compatible, they are delicate and often difficult to insert along specific trajectories or lines of insertion. During typical implantation, a surgeon feeds the probe into the brain through an aperture in the skull. In this process, the surgeon has very little control over the distal end of the probe. In order to provide more rigidity to the probe to overcome this problem, a removable stylet may be inserted into the probe before implantation. Still, veering from the intended line of insertion is not altogether prevented by introduction of a stylet to the probe.
- There is a continuing significant need in the field of intracranial treatment, particularly with insertion of probes into the interior of the brain, for improvements in accuracy of insertion and avoidance of injury, while retaining efficiency and ease of use.
- In addition, there is a need in the field of intracranial treatment to minimize the invasiveness of intracranial treatment and to reduce the number of instruments which penetrate brain tissue or the number of times a single instrument must penetrate brain tissue.
- Furthermore, there is a need in the field of intracranial treatment to provide the ability to precisely locate the position of a probe during insertion to ensure proper positioning.
- It is a primary object of the invention to provide an improved depth probe for intracranial treatment of a patient that overcomes some of the problems and shortcomings of the prior art.
- Another object of the invention is to provide a novel depth probe that is simple in structure and operation in order to facilitate intracranial procedures.
- Another object of the invention is to provide an exceptional depth probe having a body adapted to avoid extensive trauma to and scarring of brain tissue.
- Another object of the invention is to provide an excellent depth probe having a body that includes contacts for stimulation and/or for monitoring of the brain.
- Another object of the invention is to provide a desirable depth probe having a lumen for receiving and guiding an inner catheter for the delivery of a drug to targeted brain tissue and that can remain in position when the inner catheter is removed, thereby permitting repeated insertions of different inner catheters without extended contact with brain tissue during insertion.
- Another object of the invention is to provide an exceptional depth probe that provides an attached connector conductively connected to a plurality of monitoring and sensing elements for efficient and effective transmission of readings from the elements to external analysis and control devices.
- Yet another object of the invention is to provide a novel depth probe having a distal portion provided with an inflatable balloon capable of sealing off the insertion tract formed by the probe to prevent a drug being introduced into the brain by the probe from migrating back through the tract and further allows for the monitoring of cellular function within the brain prior to and after introduction of the drug.
- The invention is for a depth probe utilized to provide intracranial treatment of a patient. The depth probe comprises a body having a distal portion with at least one aperture and at least one element, a lumen defined by the body that communicates between an opening and the aperture, and a proximal portion with at least one proximal-contact. The proximal-contact is conductively connected with the element. The term “conductively connected” is meant to include a connection via a lead in the form of a wire or fiber-optic bundle for the transmission of electrical and/or optical signals.
- A number of highly preferred embodiments have the lumen sized to receive an inner catheter adapted to transfer a fluid with a tissue region within the patient's brain. In other embodiments, the body is made from substantially inflexible material.
- One preferred embodiment finds the opening on the body having a tapered fitting so that a pumping instrument can be connected to the probe at the fitting for the transfer of a fluid with a tissue region of the patient's brain. Much preferred is where the opening is at the proximal end of the body and coaxial with the lumen. Also preferred is where the aperture is in axial alignment with the lumen.
- In another desirable embodiment, the distal end of the probe is closed and the aperture is spaced away from the distal end along the distal portion. More desirable is where the body has at least first and second apertures in communication with the lumen, each aperture being spaced axially along the distal portion. Highly desirable is where the probe has first and second apertures communicating with the lumen that are spaced radially about the body's axis along the distal portion.
- In certain preferred cases, the element is a contact that can provide electrical stimulation to tissue regions within the patient's brain. Also desirable is where the element is a contact that monitors activity, preferably electrical activity, within the patient's brain. More desirable is where the probe has a plurality of contacts spaced axially along its distal portion, each of these contacts being a macro-contact that collars, i.e., circumscribes, the body. Highly desirable is where the contact is a micro-contact and preferably where the probe has a plurality of micro-contacts spaced axially and radially along its distal portion.
- Another appreciated embodiment finds the element to be a sensor. Much preferred is where the sensor senses chemical activity within the brain. Another element found desirable is where it is a location marker that allows the position of the distal portion of the probe to be identified when it is inserted into the brain. This embodiment is especially desirable when the marker is adapted to be identified, i.e. seen, under magnetic resonance imaging.
- One very preferred example of this invention is where there are a plurality of proximal-contacts and a connector adapted to receive these proximal-contacts is secured to the body. It is desirable that each of these proximal-contacts be in electrical communication with a micro-contact. More desirable is where the connector extends outward from the body and has a housing formed to position the proximal-contacts in a linear array. The connector in this embodiment has a lead-conduit extending from this housing that connects it to the body of the probe. A highly preferred embodiment finds the connector as being firmly attached to the body.
- Another highly desirable embodiment is where the proximal portion of the body has a first diameter and its distal portion has a second diameter such that the second diameter is less than the first diameter. Having this structure, the degree of contact with the tissue region by the body is reduced when the probe is inserted into the brain.
- Another interesting aspect of this invention finds a depth probe comprising a body having a distal portion with at least one aperture and one element, a lumen defined by the body that communicates between an opening and the aperture, and a conduit extending from its proximal portion to an inflatable balloon secured upon its distal portion. Much desired is where the balloon is inflatable with at least one drug and the balloon is formed from a material permeable to this drug so that the drug can be introduced into the tissue region through the balloon. Also preferred is where the balloon is adapted to seal upon inflation the tract created by the probe upon its insertion into the brain.
- A most desirable embodiment has the balloon positioned along the distal portion of the body at a point proximal to the aperture. Highly preferred is where the balloon is positioned along the distal portion and is also proximal to the element on the probe.
- In a very appreciated example, this probe also includes at least one proximal-contact along a proximal portion at its proximal end. The proximal-contact is conductively connected with the element through a lead.
-
FIG. 1 is a perspective view of a preferred depth probe having a connector extending outward from the body in accordance with this invention with cut-away sections to reveal and dashed lines to represent otherwise unseen internal features. -
FIGS. 2A and 2B are perspective views of the distal portions of alternate preferred depth probes in accordance with this invention with dashed lines to represent otherwise unseen internal features. -
FIG. 3 is a perspective view of another preferred depth probe in accordance with this invention receiving an inner catheter with cut-away sections to reveal and dashed lines to represent otherwise unseen internal features. -
FIG. 4 is a perspective view of an alternate embodiment of the depth probe having a connector attached to the body in accordance with this invention with a cut-away section. -
FIG. 5A is a perspective view of a preferred depth probe having a balloon shown deflated in accordance with this invention with cut-away sections to reveal and dashed lines to represent otherwise unseen internal features. -
FIG. 5B is the distal end of the depth probe ofFIG. 5A showing the balloon inflated with cut-away sections to reveal and dashed lines to represent otherwise unseen internal features. -
FIG. 6 is a schematic view illustrating the depth probe ofFIGS. 5A and 5B positioned within the brain. - The figures illustrate preferred embodiments of an improved depth probe for intracranial treatment of a patient in accordance with this invention.
FIG. 1 is a perspective view ofdepth probe 10 having an elongated,tubular body 12 extending fromproximal end 14 todistal end 16.Body 12 preferably has a diameter between about 0.6 and 3.0 millimeters, most preferably about 1.0 millimeter. - As seen in
FIG. 1 ,body 12 includeselements 18 secured todistal portion 20 atdistal end 16.Body 12 is also provided withlumen 22 extending from opening 24 atproximal end 14 and in communication withaperture 26.Lumen 22 is a tubular channel extending for some length withinbody 12, preferably having a diameter of 0.5 millimeters or less.Body 12 is open atdistal end 16 to formaperture 26.Opening 24 andaperture 26 are coaxial withlumen 22 alongcentral axis 28 ofbody 12. -
Elements 18 are conductively connected by leads 30 (seen inFIG. 1 running alongside lumen 22) to proximal-contacts 32. Leads 30 can be in the form of electrical wiring or a fiber-optic bundle. Proximal-contacts 32 are mounted alongproximal portion 34 ofbody 12. Whendepth probe 10 is inserted into the brain, proximal-contacts 32 remain outside of the patient. Proximal-contacts 32 are preferably formed from stainless steel or similar alloys or materials that are non-corrosive conductors and that can endure sterilization. -
Depth probe 10 can be substantially flexible, formed from bio-compatible materials such as polyurethane, silicone, or polyimide.Body 12 can also be in the form of a cannula wherebody 12 is made from a substantially rigid material that is preferably MRI safe/compatible. Such preferable materials are platinum, titanium, polyimide-coated glass, and other non-ferrous alloys. During surgery, when in the form of a cannula,depth probe 10 may be used with a stereotatic frame or a frameless guidance system to accurately position the catheter within the brain. - As seen in
FIGS. 2A and 2B , preferred embodiments ofdepth probe 10 can have a closeddistal end 16 and a plurality ofapertures 26, eachaperture 26 in communication withlumen 22.Apertures 26 inFIG. 2A are positioned abovedistal end 16 and spaced in axial alignment withaxis 28 alongdistal portion 20.Apertures 26 inFIG. 2B are shown axially and radially spaced aboutaxis 28. One skilled in the art will recognize that these configurations can also include anaperture 26 forming an opendistal end 16 as depicted inFIG. 1 . -
Body 12 ofdepth probe 10 may also include adistal portion 20 having a reduced diameter as illustrated inFIG. 3 . Such a configuration fordistal portion 20 allows for reduced injury to the surrounding tissue regions during the insertion ofdepth probe 10 into the brain. - As depicted in
FIG. 3 ,lumen 22 is preferably sized so as to be able to receive aninner catheter 36, i.e.,lumen 22 is provided with a diameter slightly greater than the outside diameter ofinner catheter 36. After positioning thedistal end 16 ofdepth probe 10 in a targeted region of the brain,inner catheter 36 can be inserted intoopening 24 and guided bylumen 22 to this tissue area.Inner catheter 36 can be withdrawn and reinserted or differentinner catheters 36 can be inserted intodepth probe 10 without reinserting orrepositioning depth probe 10.Inner catheter 36 is preferably polyimide, polyimide-coated glass or other similar material. Applicant notes that one such preferred catheter is disclosed in U.S. patent application Ser. No. 10/423,587 filed by Applicant on Apr. 25, 2003, the disclosure of which is incorporated by reference herein. -
Proximal end 14 ofbody 12 is provided with atapered fitting 38, preferably a male luer conical fitting, to provide for a detachable fluid-tight coupling with some external device. The proximal end ofinner catheter 36 is provided with a taperedcoupler 40, preferably a luer coupler that has female luer fittings at both of its ends.Tapered coupler 40 enablesinner catheter 36 to form a liquid-tight joint withdepth probe 10 wheninner catheter 36 is fully inserted intolumen 22 throughopening 24.Coupler 40 enablesinner catheter 36 to be operatively connected by tubing to an external piece of equipment such as a pump. One skilled in the art will recognize thatinner catheter 36 could also be connected to internal instrumentation having pumping capability. This process enables fluids such as drugs to be administered to the brain throughinner catheter 36. -
Elements 18 provide for monitoring of brain activity, for stimulating brain tissue or for serving as a location beacon to aid in determining the precise position ofdistal portion 20 within the brain.Elements 18 can take the form ofcontacts 42, as illustrated inFIGS. 1-6 .Contacts 42 comprise devices such aselectrodes 44 designed to monitor brain activity in a selected tissue region of thebrain 46 through the sensing of electrical and/or electrochemical changes within the brain as well aselectrodes 48 designed to provide electrical stimulation to specific areas of the brain. Electrodes serving ascontacts 42 are preferably constructed from platinum, platinum-iridium or other bio-compatible conductive material. Electrodes can be macro-contacts 49 that circumscribe orband body 12 ormicro-contacts 50 capable of measuring electrical changes at the level of a single neuron. -
Elements 18 can also can take the form of asensor 52 as depicted inFIG. 3 .Sensors 52 are designed to monitor brain activity within select tissue regions through the sensing of electrical, electrochemical, chemical, temperature or pressure changes within the brain.Sensors 52 can be electrochemical and optical transducers designed to measure chemical, pressure, temperature, cerebral blood flow and other physiological changes in the brain. Such devices are known in the art and are preferably less than about 2 millimeters long.Sensor 52 is preferably in the form of a chemical sensor. -
Elements 18 may further be in the form of alocation marker 54 as seen inFIGS. 5A and 5B .Location marker 54 is preferably a structure comprised of a non-ferrous material known in the art such as gold or tungsten that has an image signal intensity suitable for proton magnetic resonance imaging (MRI) with most commercial machines and is also sufficiently x-ray opaque for satisfactory imaging using computed tomographic scanning (CT) or on X-ray.Location marker 54 can also be comprised of a sensor capable of measuring voltages induced by a transmitted magnetic field that can be used to identify the position and orientation of the sensor within that field. -
Elements 18 may be positioned on both the distal and proximal sides ofapertures 26 alongdistal portion 20 as seen inFIGS. 2A and 2B . This configuration allows for monitoring of cellular function within the tissue region of thebrain 46 being targeted prior to treatment to verify the presence of diseased brain cells. Upon verification of diseased tissue within the targeted region, delivery of a drug or other treatment agent can commence throughdepth probe 10 while monitoring of thetissue region 46 continues concurrently with such treatment. This can have particular value in the treatment of different tissue regions of the brain for movement disorders such as Parkinson's Disease. -
FIGS. 1, 2 , 5A and 5B show that macro-contacts 49 are spaced axially alongdistal portion 20. Micro-contacts 50 can be spaced axially alongdistal portion 20 as illustrated inFIG. 4 or spaced radially aroundbody 12 as shown inFIG. 1 . -
FIGS. 5A and 5B illustrate adepth probe 10 having aninflatable balloon 56 rigidly mounted todistal portion 20, preferably above at least oneelement 18 and at least oneaperture 26. As seen inFIG. 5A , aconduit 58 entersbody 12 alongproximal portion 34 and runs alongsidelumen 22, terminating atballoon 56.Conduit 58 is preferably tubing made of polyurethane.Conduit 58 provides for the introduction of a fluid to inflateballoon 56 and, if necessary to withdraw fluid fromballoon 56 to cause deflation.Conduit 58 originates atinjection port 60 that can be operatively connected to anexternal device 62 such as a pump to dispense or receive fluid. - As depicted in
FIG. 6 , following placement ofdistal portion 20 ofdepth probe 10 within the brain,balloon 56 can be inflated to block or occlude theinsertion tract 64 created during the insertion process so that any drug administered to thebrain 46 throughaperture 26 cannot migrate back through that tract.Balloon 56 is preferably made from an elastomeric material to achieve complete deflation ofballoon 56 whendepth probe 10 is later withdrawn from the brain. - In certain embodiments,
balloon 56 is permeable.Balloon 56 in these embodiments can be inflated with a drug or other fluid intended to be administered to the brain whereby the drug then permeates through the wall ofballoon 56 to treat the tissue region of thebrain 46 surroundingballoon 56. In this manner, a drug can be introduced to one targeted tissue region of the brain delivered bydepth probe 10 throughaperture 26 at the same time the same or a different drug is transferred to another selected tissue region throughpermeable balloon 56.Balloon 56 is preferably adapted to administering a drug to the brain slowly over a period of time, thereby allowing for the effective introduction of the drug to the desired tissue region. This is especially desirable where there is a void in the particular tissue region due to some structure such as a tumor being removed. Inflatingballoon 56 within the void permits the medication to be more effectively transferred to all of the affected tissue that surrounds the outside of the balloon. - One skilled in the art will recognize that
balloon 56 can be made permeable by formingballoon 56 from a naturally porous material such as polytetrafluroethylene (PTFE) or from an elastomeric material having perforations formed in the wall of the balloon. The balloon wall is preferably from 0.5 to 5.0 mils in thickness. Where the balloon wall is perforated, an array of minute perforations, each having a diameter of 5 to 30 microns, is preferably uniformly spaced apart and concentrated along a centralband circumscribing balloon 56. Concentration of the perforations within such a region in the middle ofballoon 56 provides for focused delivery of the drug by limiting the area of permeation to just the surface area ofballoon 56 making conforming contact with the surrounding brain tissue. - Tapered fitting 38 enables
depth probe 10, as shown inFIG. 6 , to form a liquid-tight seal with tubing or similar conduit having a female luer connector. In this manner, opening 24 ofbody 12 is operatively connected by the tubing to an external instrument such aspumping equipment 66. One skilled in the art will recognize thatdepth probe 10 could also be connected to internal instrumentation having pumping capability. Such equipment allows fluids to be transferred to or from tissue region of thebrain 46 through anyaperture 26. Drugs can then be administered to the brain, cerebral spinal fluid can be withdrawn, or both. -
Depth probe 10, as illustrated inFIGS. 1 and 4 , can also include aconnector 68.Connector 68 comprises ahousing 69 mounting alinear array 70 of proximal-contacts.Connector 68 is conductively connected viaadditional leads 30 toelements 18, preferably micro-contacts 50, alongdistal portion 20.Connector 68 can be rigidly mounted tobody 12 along itsproximal portion 34 as shown inFIG. 4 . -
Connector 68 can also extend outward frombody 12 as seen inFIG. 1 .Connector 68 in this embodiment is secured tobody 12 by lead-conduit 72. Leads 30 that originate atconnector 68 pass through lead-conduit 72 before enteringbody 12 at a point alongproximate portion 34 to proceed alonglumen 22 to thecorresponding elements 18. - One skilled in the art will readily recognize that proximal-
contacts 32 are in an axial alignment that adapts them to being conductively connected to an external connector (not shown) in operative communication with a computer or similar instrument having a conventional output display and monitor with a suitable power source. This enables the brain activity sensed byelements 18 linked to these proximal-contacts to be recorded and/or analyzed and/or control overelements 18 to be exercised. - Although the invention has been described in conjunction with specific embodiments thereof, it is evident that many alternatives, modifications and variations will be apparent to those skilled in the art. Accordingly, it is intended to embrace all such alternatives, modifications and variations that fall within the spirit and broad scope of the appended claims.
Claims (31)
1. A depth probe for intracranial treatment of a patient comprising:
a body extending from a proximal end to a distal end and having an opening;
a distal portion at the distal end having at least one aperture and at least one element;
a lumen defined by the body in communication with respect to the opening and the aperture; and
a proximal portion at the proximal end having at least one proximal-contact, the proximal-contact being conductively connected with the at least one element.
2. The depth probe of claim 1 wherein the body is made from substantially rigid material and the lumen is sized to receive an inner catheter for transferring a fluid with a tissue region within the patient's brain.
3. The depth probe of claim 1 wherein the proximal end includes a tapered fitting adapted to connect to a pumping instrument for transferring a fluid with a tissue region within the patient's brain.
4. The depth probe of claim 3 wherein the body has an axis and the opening is at the proximal end and coaxial with the lumen.
5. The depth probe of claim 4 wherein at least one aperture is in axial alignment with the lumen.
6. The depth probe of claim 4 wherein the distal end is closed, the aperture being spaced from the distal end along the distal portion.
7. The depth probe of claim 6 wherein the body has at least first and second apertures in communication with respect to the lumen, the first and second apertures being spaced axially along the distal portion.
8. The depth probe of claim 6 wherein the body has at least first and second apertures in communication with respect to the lumen, the first and second apertures being spaced radially about the axis along the distal portion.
9. The depth probe of claim 4 wherein the element is a contact that provides electrical stimulation to a tissue region within the patient's brain.
10. The depth probe of claim 4 wherein the element is at least one contact that monitors activity within the patient's brain.
11. The depth probe of claim 10 wherein the contact monitors electrical activity within the patient's brain.
12. The depth probe of claim 10 wherein the at least one contact is a plurality of contacts circumscribing the body and spaced axially along the distal portion.
13. The depth probe of claim 10 wherein the contact is a micro-contact.
14. The depth probe of claim 13 wherein the at least one contact is a plurality of micro-contacts spaced axially and radially along the distal portion.
15. The depth probe of claim 4 wherein the element is at least one sensor.
16. The depth probe of claim 15 wherein the sensor senses chemical activity within the patient's brain.
17. The depth probe of claim 4 wherein the element is a location marker to identify the position of the distal portion when the probe is inserted into the brain.
18. The depth probe of claim 17 wherein the location marker is adapted to be identified by magnetic resonance imaging.
19. The depth probe of claim 1 wherein the proximal portion includes a plurality of proximal-contacts and a connector adapted to receive the proximal-contacts is secured with respect to the body.
20. The depth probe of claim 19 wherein each of the proximal-contacts is in electrical communication with a micro-contact.
21. The depth probe of claim 19 wherein the connector extends outward from the body, the connector having a housing formed to position the proximal-contacts in a linear array and a lead-conduit extending from the housing to the body.
22. The depth probe of claim 19 wherein the connector is firmly attached to the body.
23. The depth probe of claim 1 wherein the proximal portion has a first diameter and the distal portion has a second diameter such that the second diameter is less than the first diameter to reduce the degree of contact with the tissue region by the body when the probe is inserted into the brain.
24. The depth probe of claim 1 wherein the lumen is sized to receive an inner catheter for transferring a fluid with a tissue region within the patient's brain.
25. A depth probe for intracranial treatment of a patient comprising:
a body extending from a proximal end to a distal end and having an opening;
a distal portion at the distal end having at least one aperture and at least one element;
a lumen defined by the body in communication with respect to the opening and the aperture; and
a conduit extending from a proximal portion at the proximal end to an inflatable balloon secured to the distal portion.
26. The depth probe of claim 25 wherein the balloon is inflatable with at least one drug and the balloon is formed from a material permeable to the drug such that the drug can be introduced into the tissue region through the balloon.
27. The depth probe of claim 25 wherein the balloon is adapted to seal upon inflation a tract created upon insertion of the probe into the brain.
28. The depth probe of claim 25 wherein the balloon is positioned along the distal portion proximal to the aperture.
29. The depth probe of claim 25 wherein the balloon is positioned along the distal portion proximal to the element.
30. The depth probe of claim 25 wherein the lumen is sized to receive an inner catheter for transferring a fluid with a tissue region within the patient's brain.
31. The depth probe of claim 25 further comprising a proximal portion at the proximal end having at least one proximal-contact conductively connected with the element.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11/262,377 US20060058743A1 (en) | 2003-04-25 | 2005-10-28 | Depth probe for intracranial treatment |
US11/736,828 US7608064B2 (en) | 2003-04-25 | 2007-04-18 | Depth probe for intracranial treatment |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/423,587 US7241283B2 (en) | 2003-04-25 | 2003-04-25 | Method for intracranial catheter treatment of brain tissue |
US11/262,377 US20060058743A1 (en) | 2003-04-25 | 2005-10-28 | Depth probe for intracranial treatment |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/423,587 Continuation-In-Part US7241283B2 (en) | 2003-04-25 | 2003-04-25 | Method for intracranial catheter treatment of brain tissue |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/736,828 Continuation US7608064B2 (en) | 2003-04-25 | 2007-04-18 | Depth probe for intracranial treatment |
Publications (1)
Publication Number | Publication Date |
---|---|
US20060058743A1 true US20060058743A1 (en) | 2006-03-16 |
Family
ID=33299158
Family Applications (7)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/423,587 Expired - Lifetime US7241283B2 (en) | 2003-04-25 | 2003-04-25 | Method for intracranial catheter treatment of brain tissue |
US11/262,375 Expired - Lifetime US7322954B2 (en) | 2003-04-25 | 2005-10-28 | Catheter assembly for intracranial treatment using dual lumens |
US11/262,367 Expired - Lifetime US7255686B2 (en) | 2003-04-25 | 2005-10-28 | Catheter assembly for intracranial treatment |
US11/262,377 Abandoned US20060058743A1 (en) | 2003-04-25 | 2005-10-28 | Depth probe for intracranial treatment |
US11/262,376 Expired - Lifetime US7465292B2 (en) | 2003-04-25 | 2005-10-28 | Catheter system for intracranial treatment |
US11/696,531 Active 2025-09-11 US7972308B2 (en) | 2003-04-25 | 2007-04-04 | Intracranial catheter assembly for precise treatment of brain tissue |
US11/736,828 Expired - Lifetime US7608064B2 (en) | 2003-04-25 | 2007-04-18 | Depth probe for intracranial treatment |
Family Applications Before (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/423,587 Expired - Lifetime US7241283B2 (en) | 2003-04-25 | 2003-04-25 | Method for intracranial catheter treatment of brain tissue |
US11/262,375 Expired - Lifetime US7322954B2 (en) | 2003-04-25 | 2005-10-28 | Catheter assembly for intracranial treatment using dual lumens |
US11/262,367 Expired - Lifetime US7255686B2 (en) | 2003-04-25 | 2005-10-28 | Catheter assembly for intracranial treatment |
Family Applications After (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/262,376 Expired - Lifetime US7465292B2 (en) | 2003-04-25 | 2005-10-28 | Catheter system for intracranial treatment |
US11/696,531 Active 2025-09-11 US7972308B2 (en) | 2003-04-25 | 2007-04-04 | Intracranial catheter assembly for precise treatment of brain tissue |
US11/736,828 Expired - Lifetime US7608064B2 (en) | 2003-04-25 | 2007-04-18 | Depth probe for intracranial treatment |
Country Status (6)
Country | Link |
---|---|
US (7) | US7241283B2 (en) |
EP (1) | EP1622659B1 (en) |
AT (1) | ATE468148T1 (en) |
CA (1) | CA2527193C (en) |
DE (1) | DE602004027234D1 (en) |
WO (1) | WO2004096314A2 (en) |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050090801A1 (en) * | 2003-10-27 | 2005-04-28 | Racz N. S. | Safety spinal catheter |
US20080275395A1 (en) * | 2006-12-22 | 2008-11-06 | Innerspace Medical, Inc. | MRI-Compatible Temperature-Sensing Catheter |
US20090187140A1 (en) * | 2008-01-17 | 2009-07-23 | Custom Medical Applications, Inc. | Flow elements for use with flexible spinal needles, needle assemblies and methods therefor |
US20100292630A1 (en) * | 2007-11-13 | 2010-11-18 | Maskin Steven L | Meibomian Gland Intraductal Diagnostic and Treatment Methods |
US20100331794A1 (en) * | 2008-01-14 | 2010-12-30 | Racz N Sandor | Flow elements for use with flexible spinal needles, needle assemblies and methods thereof |
US9888859B1 (en) * | 2013-03-14 | 2018-02-13 | Nuvasive, Inc. | Directional dilator for intraoperative monitoring |
US10603210B1 (en) | 2017-02-02 | 2020-03-31 | Mgd Innovations, Llc | Meibomian gland probing with blood product injection |
US11298043B2 (en) | 2016-08-30 | 2022-04-12 | The Regents Of The University Of California | Methods for biomedical targeting and delivery and devices and systems for practicing the same |
US11497576B2 (en) | 2017-07-17 | 2022-11-15 | Voyager Therapeutics, Inc. | Trajectory array guide system |
Families Citing this family (122)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7241283B2 (en) * | 2003-04-25 | 2007-07-10 | Ad-Tech Medical Instrument Corp. | Method for intracranial catheter treatment of brain tissue |
WO2005067792A1 (en) * | 2004-01-12 | 2005-07-28 | Calypso Medical Technologies, Inc. | Methods and apparatus for stimulating and/or sensing neurons in a patient |
US20050222518A1 (en) * | 2004-04-06 | 2005-10-06 | Genocell, Llc | Biopsy and injection catheters |
MX349748B (en) * | 2004-10-05 | 2017-08-09 | Genzyme Corp * | Stepped cannula. |
US20060129126A1 (en) * | 2004-11-19 | 2006-06-15 | Kaplitt Michael G | Infusion device and method for infusing material into the brain of a patient |
US20060229573A1 (en) * | 2005-04-08 | 2006-10-12 | Mckinley Medical L.L.L.P. | Adjustable infusion catheter |
US8002730B2 (en) * | 2005-04-29 | 2011-08-23 | Medtronic, Inc. | Anti-thrombogenic venous shunt system and method |
US9307925B2 (en) | 2005-06-16 | 2016-04-12 | Aaken Laboratories | Methods and systems for generating electrical property maps of biological structures |
WO2007022050A1 (en) * | 2005-08-12 | 2007-02-22 | Vance Products Incorporated, D/B/A/ Cook Urological Incorporated | Drainage catheter with extended inflation lumen |
FR2889813B1 (en) * | 2005-08-18 | 2008-06-06 | Assist Publ Hopitaux De Paris | INTRA-CEREBRAL PROBE AND DEVICE FOR TREATING NEUROLOGICAL OR PSYCHIATRIC DYSFUNCTIONS |
EP1928557B1 (en) * | 2005-08-23 | 2018-06-06 | The Regents of The University of California | Reflux resistant cannula and system for chronic delivery of therapeutic agents using convection-enhanced delivery |
US9042974B2 (en) * | 2005-09-12 | 2015-05-26 | New York University | Apparatus and method for monitoring and treatment of brain disorders |
AU2006320611A1 (en) | 2005-11-29 | 2007-06-07 | Surgi-Vision, Inc. | MRI-guided localization and/or lead placement systems, related methods, devices and computer program products |
WO2007087560A2 (en) * | 2006-01-26 | 2007-08-02 | The Board Of Trustees Of The University Of Illinois | Stroke inducing and monitoring system and method for using the same |
US20070232898A1 (en) * | 2006-03-31 | 2007-10-04 | Medtronic Vascular, Inc. | Telescoping Catheter With Electromagnetic Coils for Imaging and Navigation During Cardiac Procedures |
US8112292B2 (en) | 2006-04-21 | 2012-02-07 | Medtronic Navigation, Inc. | Method and apparatus for optimizing a therapy |
US20080082036A1 (en) * | 2006-04-25 | 2008-04-03 | Medtronic, Inc. | Cerebrospinal fluid shunt having long term anti-occlusion agent delivery |
GB0616411D0 (en) | 2006-08-18 | 2006-09-27 | Renishaw Plc | Neurosurgical instruments |
US8449503B2 (en) | 2010-11-30 | 2013-05-28 | Custom Medical Applications | Neural injection system and related methods |
US8377005B2 (en) * | 2006-09-11 | 2013-02-19 | Custom Medical Applications | Neural injection system and related methods |
US9888940B2 (en) | 2006-09-11 | 2018-02-13 | Custom Medical Applications | Neural injection system and related methods |
GB2442209B (en) * | 2006-09-28 | 2012-01-18 | Probe Scient Ltd | Molecular exchange device |
US8660635B2 (en) | 2006-09-29 | 2014-02-25 | Medtronic, Inc. | Method and apparatus for optimizing a computer assisted surgical procedure |
US10632237B2 (en) | 2006-10-09 | 2020-04-28 | Minnetronix, Inc. | Tangential flow filter system for the filtration of materials from biologic fluids |
EP3827841B1 (en) | 2006-10-09 | 2024-04-03 | Neurofluidics, Inc. | Cerebrospinal fluid purification system |
US10850235B2 (en) | 2006-10-09 | 2020-12-01 | Minnetronix, Inc. | Method for filtering cerebrospinal fluid (CSF) including monitoring CSF flow |
US7766394B2 (en) * | 2006-10-30 | 2010-08-03 | Medtronic, Inc. | Breakaway connectors and systems |
US7819842B2 (en) * | 2006-11-21 | 2010-10-26 | Medtronic, Inc. | Chronically implantable guide tube for repeated intermittent delivery of materials or fluids to targeted tissue sites |
IL187667A (en) * | 2006-11-27 | 2011-12-29 | Mediguide Ltd | System and method for navigating a surgical needle toward an organ of the body of a patient |
US7744559B2 (en) * | 2006-12-19 | 2010-06-29 | Cytyc Corporation | Systems and methods for drug infusion with feedback control |
US7844345B2 (en) | 2007-02-08 | 2010-11-30 | Neuropace, Inc. | Drug eluting lead systems |
US7813811B2 (en) * | 2007-02-08 | 2010-10-12 | Neuropace, Inc. | Refillable reservoir lead systems |
US10065021B2 (en) * | 2007-05-17 | 2018-09-04 | Medgenesis Therapeutix, Inc. | Convection-enhanced delivery catheter with removable stiffening member and method for using same |
US8858490B2 (en) | 2007-07-18 | 2014-10-14 | Silk Road Medical, Inc. | Systems and methods for treating a carotid artery |
ES2913223T3 (en) | 2007-07-18 | 2022-06-01 | Silk Road Medical Inc | Systems for establishing retrograde carotid arterial blood flow |
WO2009029508A1 (en) * | 2007-08-28 | 2009-03-05 | Johnnie B. Byrd, Sr. Alzheimer's Center And Research Institute, Inc. | Intracranial catheter and methods of use |
US8315689B2 (en) | 2007-09-24 | 2012-11-20 | MRI Interventions, Inc. | MRI surgical systems for real-time visualizations using MRI image data and predefined data of surgical tools |
US8195272B2 (en) * | 2007-09-24 | 2012-06-05 | MRI Interventions, Inc. | MRI-compatible patches and methods for using the same |
CA2700523A1 (en) * | 2007-09-24 | 2009-04-02 | Surgivision, Inc. | Mri-guided medical interventional systems and methods |
US8340743B2 (en) * | 2007-11-21 | 2012-12-25 | MRI Interventions, Inc. | Methods, systems and computer program products for positioning a guidance apparatus relative to a patient |
US8480626B2 (en) | 2007-11-30 | 2013-07-09 | Medtronic, Inc. | Infusion catheter assembly with reduced backflow |
JP2011510796A (en) | 2008-02-05 | 2011-04-07 | シルク・ロード・メディカル・インコーポレイテッド | Intervention catheter system and method |
GB2457468B (en) * | 2008-02-13 | 2012-11-21 | Probe Scient Ltd | molecular exchange device |
US8038177B2 (en) * | 2008-02-25 | 2011-10-18 | Oil States Industries, Inc. | Pressure isolation system for flexible pipe joints |
WO2009117069A2 (en) * | 2008-03-17 | 2009-09-24 | Surgivision, Inc. | Low profile medical devices with internal drive shafts that cooperate with releasably engageable drive tools and related methods |
US20090270755A1 (en) * | 2008-04-29 | 2009-10-29 | Microsoft Corporation | Pedometer for the brain |
US8165658B2 (en) * | 2008-09-26 | 2012-04-24 | Medtronic, Inc. | Method and apparatus for positioning a guide relative to a base |
EP2341858B1 (en) | 2008-10-01 | 2014-02-12 | Sherwin Hua | System for wire-guided pedicle screw stabilization of spinal vertebrae |
EP2379129B1 (en) | 2008-12-23 | 2017-09-13 | Silk Road Medical, Inc. | Methods and systems for treatment of acute ischemic stroke |
US10197240B2 (en) * | 2009-01-09 | 2019-02-05 | Cree, Inc. | Lighting device |
US20100191168A1 (en) | 2009-01-29 | 2010-07-29 | Trustees Of Tufts College | Endovascular cerebrospinal fluid shunt |
WO2010093712A2 (en) * | 2009-02-10 | 2010-08-19 | Innerspace Medical, Inc. | Bolt stop system for use in accessing intracranial space |
EP2440131B1 (en) | 2009-06-08 | 2018-04-04 | MRI Interventions, Inc. | Mri-guided interventional systems that can track and generate dynamic visualizations of flexible intrabody devices in near real time |
US8396532B2 (en) | 2009-06-16 | 2013-03-12 | MRI Interventions, Inc. | MRI-guided devices and MRI-guided interventional systems that can track and generate dynamic visualizations of the devices in near real time |
US8128129B2 (en) * | 2009-07-15 | 2012-03-06 | Oil States Industries, Inc. | Double-ended flexible pipe joint having stacked co-axial primary and secondary annular elastomeric flex elements |
AU2010300373B2 (en) | 2009-10-02 | 2014-04-24 | Medtronic-Xomed, Inc. | Endotracheal tube apparatus |
US8449504B2 (en) | 2009-11-11 | 2013-05-28 | Calibra Medical, Inc. | Wearable infusion device and system |
CN102791185A (en) * | 2009-12-21 | 2012-11-21 | S·华 | Insertion of medical devices through non-orthogonal and orthogonal trajectories within the cranium and methods of using |
FR2955477B1 (en) | 2010-01-25 | 2012-03-23 | Dixi Microtechniques | INTRACEREBRAL ELECTRODE |
US10105485B2 (en) | 2010-04-16 | 2018-10-23 | MRI Interventions, Inc. | MRI surgical systems including MRI-compatible surgical cannulae for transferring a substance to and/or from a patient |
US9220501B2 (en) | 2010-09-30 | 2015-12-29 | Ethicon Endo-Surgery, Inc. | Tissue thickness compensators |
US8971993B2 (en) | 2010-11-19 | 2015-03-03 | Mediguide Ltd. | Systems and methods for navigating a surgical device |
WO2012156478A1 (en) | 2011-05-17 | 2012-11-22 | Joanneum Research Forschungsgesellschaft Mbh | Catheter having a healing dummy |
US20130172774A1 (en) * | 2011-07-01 | 2013-07-04 | Neuropace, Inc. | Systems and Methods for Assessing the Effectiveness of a Therapy Including a Drug Regimen Using an Implantable Medical Device |
US10779855B2 (en) | 2011-08-05 | 2020-09-22 | Route 92 Medical, Inc. | Methods and systems for treatment of acute ischemic stroke |
EP2739217B1 (en) | 2011-08-05 | 2022-07-20 | Route 92 Medical, Inc. | Systems for treatment of acute ischemic stroke |
US9931079B2 (en) | 2012-01-04 | 2018-04-03 | Medtronic Xomed, Inc. | Clamp for securing a terminal end of a wire to a surface electrode |
US8852156B2 (en) | 2012-02-08 | 2014-10-07 | Windrose Medical, Llc. | Device for implanting medical catheters |
ES2949296T3 (en) | 2012-07-24 | 2023-09-27 | Renishaw Plc | Neurosurgical device |
US9192446B2 (en) | 2012-09-05 | 2015-11-24 | MRI Interventions, Inc. | Trajectory guide frame for MRI-guided surgeries |
CN104768480B (en) | 2012-09-10 | 2017-12-08 | 阿克拉伦特公司 | For expanding the force feed device of anatomical passageway |
WO2014047179A1 (en) * | 2012-09-19 | 2014-03-27 | University Of Virginia Patent Foundation | Method and system for enhanced imaging visualization of deep brain anatomy using infusion |
DE102012221284A1 (en) * | 2012-11-21 | 2014-05-22 | Raumedic Ag | Medical pressure sensor device and set of such a pressure sensor device and at least one removable catheter |
US9072864B2 (en) * | 2012-11-28 | 2015-07-07 | Ad-Tech Medical Instrument Corporation | Catheter with depth electrode for dual-purpose use |
US9060744B2 (en) | 2012-11-29 | 2015-06-23 | Medtronic Xomed, Inc. | Endobronchial tube apparatus |
US9308022B2 (en) | 2012-12-10 | 2016-04-12 | Nevro Corporation | Lead insertion devices and associated systems and methods |
WO2014116850A1 (en) | 2013-01-23 | 2014-07-31 | Cornell University | System and methods for multi-site activation of the thalamus |
DE102013101538C5 (en) | 2013-02-15 | 2019-03-28 | Pajunk GmbH Medizintechnologie | Set for the peripheral nerve block |
US9913594B2 (en) | 2013-03-14 | 2018-03-13 | Medtronic Xomed, Inc. | Compliant electrode for EMG endotracheal tube |
USD716441S1 (en) * | 2013-09-09 | 2014-10-28 | Acclarent, Inc. | Inflator |
US9891296B2 (en) | 2013-09-13 | 2018-02-13 | MRI Interventions, Inc. | Intrabody fluid transfer devices, systems and methods |
CN105873630B (en) * | 2013-11-22 | 2020-01-03 | 隆佩瑟尔医疗公司 | Device and method for assisted respiration by transvascular nerve stimulation |
US9265512B2 (en) | 2013-12-23 | 2016-02-23 | Silk Road Medical, Inc. | Transcarotid neurovascular catheter |
JP6637430B2 (en) | 2014-01-15 | 2020-01-29 | タフツ メディカル センター, インク.Tufts Medical Center, Inc. | Intravascular cerebrospinal fluid shunt |
US9737696B2 (en) | 2014-01-15 | 2017-08-22 | Tufts Medical Center, Inc. | Endovascular cerebrospinal fluid shunt |
US10369329B2 (en) * | 2014-01-30 | 2019-08-06 | Renishaw Plc | Neurosurgical apparatus and method |
US9241699B1 (en) | 2014-09-04 | 2016-01-26 | Silk Road Medical, Inc. | Methods and devices for transcarotid access |
US10155100B2 (en) * | 2014-03-27 | 2018-12-18 | Covidien Lp | Catheter positioning |
US10043284B2 (en) | 2014-05-07 | 2018-08-07 | Varian Medical Systems, Inc. | Systems and methods for real-time tumor tracking |
US9919165B2 (en) | 2014-05-07 | 2018-03-20 | Varian Medical Systems, Inc. | Systems and methods for fiducial to plan association |
US9409020B2 (en) | 2014-05-20 | 2016-08-09 | Nevro Corporation | Implanted pulse generators with reduced power consumption via signal strength/duration characteristics, and associated systems and methods |
KR20170045286A (en) | 2014-08-26 | 2017-04-26 | 아벤트, 인크. | Method and system for identification of source of chronic pain and treatment |
WO2016032384A1 (en) * | 2014-08-27 | 2016-03-03 | Neuronano Ab | Method of implantation of a medical device into neural tissue |
US11027104B2 (en) | 2014-09-04 | 2021-06-08 | Silk Road Medical, Inc. | Methods and devices for transcarotid access |
EP3753600A1 (en) | 2014-10-31 | 2020-12-23 | CereVasc, Inc. | Systems for treating hydrocephalus |
US11065019B1 (en) | 2015-02-04 | 2021-07-20 | Route 92 Medical, Inc. | Aspiration catheter systems and methods of use |
ES2770321T3 (en) | 2015-02-04 | 2020-07-01 | Route 92 Medical Inc | Rapid Aspiration Thrombectomy System |
CN104970787A (en) * | 2015-06-29 | 2015-10-14 | 苏州景昱医疗器械有限公司 | Probe contact, probe module and multiparameter monitoring system |
CN105054903A (en) * | 2015-06-29 | 2015-11-18 | 苏州景昱医疗器械有限公司 | Multi-parameter monitoring system |
US11147540B2 (en) | 2015-07-01 | 2021-10-19 | Minnetronix, Inc. | Introducer sheath and puncture tool for the introduction and placement of a catheter in tissue |
US11207461B2 (en) | 2015-07-30 | 2021-12-28 | Anoop U. R | Drug delivery system and method for controlled and continuous delivery of drugs into the brain by bypassing the blood brain barrier |
EP3842080B1 (en) | 2015-12-04 | 2023-04-12 | Minnetronix Inc. | Systems for the conditioning of cerebrospinal fluid |
US10300277B1 (en) | 2015-12-14 | 2019-05-28 | Nevro Corp. | Variable amplitude signals for neurological therapy, and associated systems and methods |
EP3393571B1 (en) | 2016-02-17 | 2024-03-06 | ClearPoint Neuro, Inc. | Intrabody surgical fluid transfer assemblies with adjustable exposed cannula to needle tip length, related systems and methods |
CN106448402B (en) * | 2016-10-26 | 2017-11-07 | 中国人民解放军第三军医大学 | Simulate the sacculus model equipment of intracranial mass lesion effect |
US10786325B1 (en) | 2016-12-15 | 2020-09-29 | Pmt Corporation | Anchor bolt fixation system |
US10905497B2 (en) | 2017-04-21 | 2021-02-02 | Clearpoint Neuro, Inc. | Surgical navigation systems |
US10835688B2 (en) | 2017-08-01 | 2020-11-17 | Tejash Patel | Enhanced needle |
AU2018322472A1 (en) | 2017-08-22 | 2020-04-02 | Medtronic Xomed, Inc. | System and method for evoking a reflex to monitor the nerves of the larynx |
US11110240B2 (en) | 2017-09-07 | 2021-09-07 | Medtronic Xomed, Inc. | Endotracheal tube with tube coating |
KR102223085B1 (en) * | 2017-11-01 | 2021-03-04 | 사회복지법인 삼성생명공익재단 | Apparatus for intracerebral injection of drugs and method for intracerebral injection of drugs |
EP3737459A4 (en) | 2018-01-30 | 2021-10-20 | Nevro Corp. | Efficient use of an implantable pulse generator battery, and associated systems and methods |
US11022664B2 (en) | 2018-05-09 | 2021-06-01 | Clearpoint Neuro, Inc. | MRI compatible intrabody fluid transfer systems and related devices and methods |
US11253237B2 (en) | 2018-05-09 | 2022-02-22 | Clearpoint Neuro, Inc. | MRI compatible intrabody fluid transfer systems and related devices and methods |
US11607523B2 (en) | 2018-05-17 | 2023-03-21 | Route 92 Medical, Inc. | Aspiration catheter systems and methods of use |
US11058875B1 (en) | 2018-09-19 | 2021-07-13 | Nevro Corp. | Motor function in spinal cord injury patients via electrical stimulation, and associated systems and methods |
US11590352B2 (en) | 2019-01-29 | 2023-02-28 | Nevro Corp. | Ramped therapeutic signals for modulating inhibitory interneurons, and associated systems and methods |
FR3092763B1 (en) | 2019-02-15 | 2021-01-29 | Dixi Medical | HYBRID INTRACEREBRAL ELECTRODE |
US11160580B2 (en) | 2019-04-24 | 2021-11-02 | Spine23 Inc. | Systems and methods for pedicle screw stabilization of spinal vertebrae |
US20200375461A1 (en) | 2019-05-28 | 2020-12-03 | Biosense Webster (Israel) Ltd. | Flexible brain probe over guidewire |
US20200375492A1 (en) | 2019-05-28 | 2020-12-03 | Biosense Webster (Israel) Ltd. | Brain signal tracking |
US11684750B2 (en) | 2019-10-08 | 2023-06-27 | Clearpoint Neuro, Inc. | Extension tube assembly and related medical fluid transfer systems and methods |
Citations (54)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4346709A (en) * | 1980-11-10 | 1982-08-31 | Alza Corporation | Drug delivery devices comprising erodible polymer and erosion rate modifier |
US4411648A (en) * | 1981-06-11 | 1983-10-25 | Board Of Regents, The University Of Texas System | Iontophoretic catheter device |
US4471779A (en) * | 1976-08-25 | 1984-09-18 | Becton, Dickinson And Company | Miniature balloon catheter |
US4613324A (en) * | 1985-06-17 | 1986-09-23 | Ghajar Jamshid B G | Method and apparatus for guiding catheter into ventricular system of human brain |
US4685901A (en) * | 1984-11-05 | 1987-08-11 | Medical Innovations Corporation | Gastro-jejunal feeding device |
US4777951A (en) * | 1986-09-19 | 1988-10-18 | Mansfield Scientific, Inc. | Procedure and catheter instrument for treating patients for aortic stenosis |
US4798586A (en) * | 1987-04-09 | 1989-01-17 | Cordis Corporation | Method and apparatus for aiding dilatation catheterization |
US4850359A (en) * | 1987-10-16 | 1989-07-25 | Ad-Tech Medical Instrument Corporation | Electrical brain-contact devices |
US4890623A (en) * | 1988-03-14 | 1990-01-02 | C. R. Bard, Inc. | Biopotential sensing device and method for making |
US4892538A (en) * | 1987-11-17 | 1990-01-09 | Brown University Research Foundation | In vivo delivery of neurotransmitters by implanted, encapsulated cells |
US4921478A (en) * | 1988-02-23 | 1990-05-01 | C. R. Bard, Inc. | Cerebral balloon angioplasty system |
US5033998A (en) * | 1984-01-20 | 1991-07-23 | Eliot Corday | Retrograde delivery of pharmacologic and diagnostic agents via venous circulation |
US5041090A (en) * | 1988-01-12 | 1991-08-20 | Scheglov Viktor I | Occluding device |
US5064654A (en) * | 1989-01-11 | 1991-11-12 | Ciba-Geigy Corporation | Mixed solvent mutually enhanced transdermal therapeutic system |
US5081990A (en) * | 1990-05-11 | 1992-01-21 | New York University | Catheter for spinal epidural injection of drugs and measurement of evoked potentials |
US5087244A (en) * | 1989-01-31 | 1992-02-11 | C. R. Bard, Inc. | Catheter and method for locally applying medication to the wall of a blood vessel or other body lumen |
US5119832A (en) * | 1989-07-11 | 1992-06-09 | Ravi Xavier | Epidural catheter with nerve stimulators |
US5154179A (en) * | 1987-07-02 | 1992-10-13 | Medical Magnetics, Inc. | Device construction and method facilitating magnetic resonance imaging of foreign objects in a body |
US5191898A (en) * | 1990-10-22 | 1993-03-09 | Millar Instruments, Inc. | Method and assembly for measuring intracranial fluid characateristics |
US5330768A (en) * | 1991-07-05 | 1994-07-19 | Massachusetts Institute Of Technology | Controlled drug delivery using polymer/pluronic blends |
US5374285A (en) * | 1992-07-31 | 1994-12-20 | Aries S.R.L. | Spinal electrode catheter |
US5423877A (en) * | 1992-05-04 | 1995-06-13 | David C. Mackey | Method and device for acute pain management by simultaneous spinal cord electrical stimulation and drug infusion |
US5458631A (en) * | 1989-01-06 | 1995-10-17 | Xavier; Ravi | Implantable catheter with electrical pulse nerve stimulators and drug delivery system |
US5505698A (en) * | 1993-10-29 | 1996-04-09 | Medtronic, Inc. | Cardioplegia catheter with elongated cuff |
US5676655A (en) * | 1994-02-09 | 1997-10-14 | University Of Iowa Research Foundation | Methods for treating tinnitus by drug microinfusion from a neural prosthesis inserted in the brain |
US5711316A (en) * | 1996-04-30 | 1998-01-27 | Medtronic, Inc. | Method of treating movement disorders by brain infusion |
US5713858A (en) * | 1995-04-28 | 1998-02-03 | Medtronic, Inc. | Permanently implantable guiding catheter |
US5728066A (en) * | 1995-12-13 | 1998-03-17 | Daneshvar; Yousef | Injection systems and methods |
US5782798A (en) * | 1996-06-26 | 1998-07-21 | Medtronic, Inc. | Techniques for treating eating disorders by brain stimulation and drug infusion |
US5792100A (en) * | 1995-05-19 | 1998-08-11 | Shantha; T. R. | Treatment method for transsphenoidal stimulation of the pituitary gland and of nerve structures |
US5792110A (en) * | 1996-06-26 | 1998-08-11 | Cunningham; Miles G. | Systems and methods for delivering therapeutic agents to selected sites in a subject |
US5795331A (en) * | 1994-01-24 | 1998-08-18 | Micro Therapeutics, Inc. | Balloon catheter for occluding aneurysms of branch vessels |
US5807328A (en) * | 1996-04-01 | 1998-09-15 | Medtronic, Inc. | Balloon catheter assembly with selectively occluded and vented lumen |
US5810767A (en) * | 1994-05-11 | 1998-09-22 | Localmed, Inc. | Method and apparatus for pressurized intraluminal drug delivery |
US5843022A (en) * | 1995-10-25 | 1998-12-01 | Scimied Life Systems, Inc. | Intravascular device utilizing fluid to extract occlusive material |
US5868704A (en) * | 1995-09-18 | 1999-02-09 | W. L. Gore & Associates, Inc. | Balloon catheter device |
US5975085A (en) * | 1997-05-01 | 1999-11-02 | Medtronic, Inc. | Method of treating schizophrenia by brain stimulation and drug infusion |
US6017323A (en) * | 1997-04-08 | 2000-01-25 | Target Therapeutics, Inc. | Balloon catheter with distal infusion section |
US6041252A (en) * | 1995-06-07 | 2000-03-21 | Ichor Medical Systems Inc. | Drug delivery system and method |
US6096021A (en) * | 1998-03-30 | 2000-08-01 | The University Of Virginia Patent Foundation | Flow arrest, double balloon technique for occluding aneurysms or blood vessels |
US6203526B1 (en) * | 1997-08-22 | 2001-03-20 | Direct Therapeutics, Inc. | Apparatus for preventing loss of a composition during a medical procedure |
US6210346B1 (en) * | 1989-10-11 | 2001-04-03 | Edwards Lifesciences Corp. | Method for inserting an intracranial catheter and for monitoring intracranial pressure in a mammal |
US6251115B1 (en) * | 1999-04-29 | 2001-06-26 | Medtronic, Inc. | Method for the medical treatment of the neurological system |
US6263225B1 (en) * | 1994-02-09 | 2001-07-17 | University Of Iowa Research Foundation | Stereotactic electrode assembly |
US6264633B1 (en) * | 1997-07-31 | 2001-07-24 | WILLY RüSCH AG | Balloon catheter |
US6283951B1 (en) * | 1996-10-11 | 2001-09-04 | Transvascular, Inc. | Systems and methods for delivering drugs to selected locations within the body |
US6510347B2 (en) * | 2000-08-17 | 2003-01-21 | William N. Borkan | Spinal cord stimulation leads |
US6527782B2 (en) * | 2000-06-07 | 2003-03-04 | Sterotaxis, Inc. | Guide for medical devices |
US6629990B2 (en) * | 2001-07-13 | 2003-10-07 | Ad-Tech Medical Instrument Corp. | Heat-removal method and apparatus for treatment of movement disorder episodes |
US6656152B2 (en) * | 2001-11-16 | 2003-12-02 | Ad-Tech Medical Instrument Corp. | Drug delivery catheter assembly with inflatable balloon |
US6733474B2 (en) * | 1996-10-10 | 2004-05-11 | Scimed Life Systems, Inc. | Catheter for tissue dilatation and drug delivery |
US6773447B2 (en) * | 2002-07-02 | 2004-08-10 | Sentient Engineering & Technology, Llc | Balloon catheter and treatment apparatus |
US6832115B2 (en) * | 2000-08-17 | 2004-12-14 | William N. Borkan | Catheter leads for the intrathecal space and method of use |
US6887229B1 (en) * | 2000-11-07 | 2005-05-03 | Pressure Products Medical Supplies Inc. | Method and apparatus for insertion of elongate instruments within a body cavity |
Family Cites Families (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3423877A (en) * | 1966-11-16 | 1969-01-28 | Us Navy | Quick acting hatch cover |
FI791570A (en) * | 1979-05-16 | 1980-11-17 | Elevator Gmbh | REGLERSYSTEM FOER HISSBATTERI |
US4613326A (en) * | 1985-07-12 | 1986-09-23 | Becton, Dickinson And Company | Two-component medication syringe assembly |
US4798856A (en) * | 1987-11-06 | 1989-01-17 | Columbian Chemicals Co. | Pigment dispersion in resin |
US4848344A (en) * | 1987-11-13 | 1989-07-18 | Cook, Inc. | Balloon guide |
US4903707A (en) * | 1988-04-22 | 1990-02-27 | Camino Laboratories | Ventricular catheter assembly |
GB8823528D0 (en) * | 1988-10-06 | 1988-11-16 | Arco Chem Co | Substantially closed cell rigid polyurethane foams |
US5108364A (en) * | 1989-02-16 | 1992-04-28 | Sumitomo Bakelte Company Limited | Monitoring catheter for medical use |
DE3922406C1 (en) * | 1989-07-07 | 1990-10-11 | B. Braun Melsungen Ag, 3508 Melsungen, De | |
US5147335A (en) * | 1989-08-24 | 1992-09-15 | Board Of Regents, The University Of Texas System | Transurethrovesical biopsy, amniocentesis and biological sampling guide |
US5009636A (en) * | 1989-12-06 | 1991-04-23 | The Kendall Company | Dual-lumen catheter apparatus and method |
US5147315A (en) * | 1990-04-06 | 1992-09-15 | C. R. Bard, Inc. | Access catheter and system for use in the female reproductive system |
EP0585072B1 (en) * | 1992-08-27 | 1997-12-29 | Dai-Ichi Kogyo Seiyaku Co., Ltd. | Ion-conductive polymer electrolyte |
US5300022A (en) * | 1992-11-12 | 1994-04-05 | Martin Klapper | Urinary catheter and bladder irrigation system |
US5792106A (en) * | 1993-12-02 | 1998-08-11 | Scimed Life Systems, Inc. | In situ stent forming catheter |
US6241734B1 (en) * | 1998-08-14 | 2001-06-05 | Kyphon, Inc. | Systems and methods for placing materials into bone |
US5441481A (en) * | 1994-05-27 | 1995-08-15 | Mishra; Pravin | Microdialysis probes and methods of use |
US6090084A (en) * | 1994-07-08 | 2000-07-18 | Daig Corporation | Shaped guiding introducers for use with a catheter for the treatment of atrial arrhythmia |
JPH08296160A (en) * | 1995-04-24 | 1996-11-12 | Ichikawa Woolen Textile Co Ltd | Heat resistant felt for product used at high temperature |
US6272370B1 (en) * | 1998-08-07 | 2001-08-07 | The Regents Of University Of Minnesota | MR-visible medical device for neurological interventions using nonlinear magnetic stereotaxis and a method imaging |
GB2327614B (en) * | 1997-07-30 | 2002-03-06 | Univ Dundee | A hypodermic needle |
US6030358A (en) * | 1997-08-08 | 2000-02-29 | Odland; Rick Matthew | Microcatheter and method for site specific therapy |
US6251315B1 (en) * | 1998-11-20 | 2001-06-26 | United Technologies Corporation | Method for disposing a laser blocking material on the interior of an airfoil |
US6544206B1 (en) * | 1999-10-14 | 2003-04-08 | Robert H. Johnston, Jr. | Dialysis access system and method |
US6336914B1 (en) * | 2000-01-13 | 2002-01-08 | Gillespie, Iii Richard D. | Releasable interlock assembly having axial and rotational engagement |
US6638268B2 (en) * | 2000-04-07 | 2003-10-28 | Imran K. Niazi | Catheter to cannulate the coronary sinus |
US6558353B2 (en) * | 2001-01-25 | 2003-05-06 | Walter A. Zohmann | Spinal needle |
DE20113545U1 (en) * | 2001-08-16 | 2001-12-20 | Rehau Ag & Co | catheter |
US7241283B2 (en) * | 2003-04-25 | 2007-07-10 | Ad-Tech Medical Instrument Corp. | Method for intracranial catheter treatment of brain tissue |
-
2003
- 2003-04-25 US US10/423,587 patent/US7241283B2/en not_active Expired - Lifetime
-
2004
- 2004-04-07 EP EP04760240A patent/EP1622659B1/en not_active Expired - Lifetime
- 2004-04-07 DE DE602004027234T patent/DE602004027234D1/en not_active Expired - Lifetime
- 2004-04-07 CA CA2527193A patent/CA2527193C/en not_active Expired - Lifetime
- 2004-04-07 WO PCT/US2004/010788 patent/WO2004096314A2/en active Application Filing
- 2004-04-07 AT AT04760240T patent/ATE468148T1/en not_active IP Right Cessation
-
2005
- 2005-10-28 US US11/262,375 patent/US7322954B2/en not_active Expired - Lifetime
- 2005-10-28 US US11/262,367 patent/US7255686B2/en not_active Expired - Lifetime
- 2005-10-28 US US11/262,377 patent/US20060058743A1/en not_active Abandoned
- 2005-10-28 US US11/262,376 patent/US7465292B2/en not_active Expired - Lifetime
-
2007
- 2007-04-04 US US11/696,531 patent/US7972308B2/en active Active
- 2007-04-18 US US11/736,828 patent/US7608064B2/en not_active Expired - Lifetime
Patent Citations (57)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4471779A (en) * | 1976-08-25 | 1984-09-18 | Becton, Dickinson And Company | Miniature balloon catheter |
US4346709A (en) * | 1980-11-10 | 1982-08-31 | Alza Corporation | Drug delivery devices comprising erodible polymer and erosion rate modifier |
US4411648A (en) * | 1981-06-11 | 1983-10-25 | Board Of Regents, The University Of Texas System | Iontophoretic catheter device |
US5033998A (en) * | 1984-01-20 | 1991-07-23 | Eliot Corday | Retrograde delivery of pharmacologic and diagnostic agents via venous circulation |
US4685901A (en) * | 1984-11-05 | 1987-08-11 | Medical Innovations Corporation | Gastro-jejunal feeding device |
US4613324A (en) * | 1985-06-17 | 1986-09-23 | Ghajar Jamshid B G | Method and apparatus for guiding catheter into ventricular system of human brain |
US4777951A (en) * | 1986-09-19 | 1988-10-18 | Mansfield Scientific, Inc. | Procedure and catheter instrument for treating patients for aortic stenosis |
US4798586A (en) * | 1987-04-09 | 1989-01-17 | Cordis Corporation | Method and apparatus for aiding dilatation catheterization |
US5154179A (en) * | 1987-07-02 | 1992-10-13 | Medical Magnetics, Inc. | Device construction and method facilitating magnetic resonance imaging of foreign objects in a body |
US4850359A (en) * | 1987-10-16 | 1989-07-25 | Ad-Tech Medical Instrument Corporation | Electrical brain-contact devices |
US4892538A (en) * | 1987-11-17 | 1990-01-09 | Brown University Research Foundation | In vivo delivery of neurotransmitters by implanted, encapsulated cells |
US5041090A (en) * | 1988-01-12 | 1991-08-20 | Scheglov Viktor I | Occluding device |
US4921478A (en) * | 1988-02-23 | 1990-05-01 | C. R. Bard, Inc. | Cerebral balloon angioplasty system |
US4890623A (en) * | 1988-03-14 | 1990-01-02 | C. R. Bard, Inc. | Biopotential sensing device and method for making |
US5458631A (en) * | 1989-01-06 | 1995-10-17 | Xavier; Ravi | Implantable catheter with electrical pulse nerve stimulators and drug delivery system |
US5064654A (en) * | 1989-01-11 | 1991-11-12 | Ciba-Geigy Corporation | Mixed solvent mutually enhanced transdermal therapeutic system |
US5087244A (en) * | 1989-01-31 | 1992-02-11 | C. R. Bard, Inc. | Catheter and method for locally applying medication to the wall of a blood vessel or other body lumen |
US5119832A (en) * | 1989-07-11 | 1992-06-09 | Ravi Xavier | Epidural catheter with nerve stimulators |
US6210346B1 (en) * | 1989-10-11 | 2001-04-03 | Edwards Lifesciences Corp. | Method for inserting an intracranial catheter and for monitoring intracranial pressure in a mammal |
US5081990A (en) * | 1990-05-11 | 1992-01-21 | New York University | Catheter for spinal epidural injection of drugs and measurement of evoked potentials |
US5191898A (en) * | 1990-10-22 | 1993-03-09 | Millar Instruments, Inc. | Method and assembly for measuring intracranial fluid characateristics |
US5330768A (en) * | 1991-07-05 | 1994-07-19 | Massachusetts Institute Of Technology | Controlled drug delivery using polymer/pluronic blends |
US5423877A (en) * | 1992-05-04 | 1995-06-13 | David C. Mackey | Method and device for acute pain management by simultaneous spinal cord electrical stimulation and drug infusion |
US5374285A (en) * | 1992-07-31 | 1994-12-20 | Aries S.R.L. | Spinal electrode catheter |
US5505698A (en) * | 1993-10-29 | 1996-04-09 | Medtronic, Inc. | Cardioplegia catheter with elongated cuff |
US5662607A (en) * | 1993-10-29 | 1997-09-02 | Medtronic, Inc. | Cardioplegia catheter with elongated cuff |
US5795331A (en) * | 1994-01-24 | 1998-08-18 | Micro Therapeutics, Inc. | Balloon catheter for occluding aneurysms of branch vessels |
US6263225B1 (en) * | 1994-02-09 | 2001-07-17 | University Of Iowa Research Foundation | Stereotactic electrode assembly |
US5697975A (en) * | 1994-02-09 | 1997-12-16 | The University Of Iowa Research Foundation | Human cerebral cortex neural prosthetic for tinnitus |
US5676655A (en) * | 1994-02-09 | 1997-10-14 | University Of Iowa Research Foundation | Methods for treating tinnitus by drug microinfusion from a neural prosthesis inserted in the brain |
US5810767A (en) * | 1994-05-11 | 1998-09-22 | Localmed, Inc. | Method and apparatus for pressurized intraluminal drug delivery |
US5713858A (en) * | 1995-04-28 | 1998-02-03 | Medtronic, Inc. | Permanently implantable guiding catheter |
US5792100A (en) * | 1995-05-19 | 1998-08-11 | Shantha; T. R. | Treatment method for transsphenoidal stimulation of the pituitary gland and of nerve structures |
US6041252A (en) * | 1995-06-07 | 2000-03-21 | Ichor Medical Systems Inc. | Drug delivery system and method |
US5868704A (en) * | 1995-09-18 | 1999-02-09 | W. L. Gore & Associates, Inc. | Balloon catheter device |
US6120477A (en) * | 1995-09-18 | 2000-09-19 | Gore Enterprise Holdings, Inc. | Balloon catheter device |
US5843022A (en) * | 1995-10-25 | 1998-12-01 | Scimied Life Systems, Inc. | Intravascular device utilizing fluid to extract occlusive material |
US5728066A (en) * | 1995-12-13 | 1998-03-17 | Daneshvar; Yousef | Injection systems and methods |
US5807328A (en) * | 1996-04-01 | 1998-09-15 | Medtronic, Inc. | Balloon catheter assembly with selectively occluded and vented lumen |
US5711316A (en) * | 1996-04-30 | 1998-01-27 | Medtronic, Inc. | Method of treating movement disorders by brain infusion |
US5792110A (en) * | 1996-06-26 | 1998-08-11 | Cunningham; Miles G. | Systems and methods for delivering therapeutic agents to selected sites in a subject |
US5782798A (en) * | 1996-06-26 | 1998-07-21 | Medtronic, Inc. | Techniques for treating eating disorders by brain stimulation and drug infusion |
US6733474B2 (en) * | 1996-10-10 | 2004-05-11 | Scimed Life Systems, Inc. | Catheter for tissue dilatation and drug delivery |
US6283951B1 (en) * | 1996-10-11 | 2001-09-04 | Transvascular, Inc. | Systems and methods for delivering drugs to selected locations within the body |
US6017323A (en) * | 1997-04-08 | 2000-01-25 | Target Therapeutics, Inc. | Balloon catheter with distal infusion section |
US5975085A (en) * | 1997-05-01 | 1999-11-02 | Medtronic, Inc. | Method of treating schizophrenia by brain stimulation and drug infusion |
US6264633B1 (en) * | 1997-07-31 | 2001-07-24 | WILLY RüSCH AG | Balloon catheter |
US6203526B1 (en) * | 1997-08-22 | 2001-03-20 | Direct Therapeutics, Inc. | Apparatus for preventing loss of a composition during a medical procedure |
US6096021A (en) * | 1998-03-30 | 2000-08-01 | The University Of Virginia Patent Foundation | Flow arrest, double balloon technique for occluding aneurysms or blood vessels |
US6251115B1 (en) * | 1999-04-29 | 2001-06-26 | Medtronic, Inc. | Method for the medical treatment of the neurological system |
US6527782B2 (en) * | 2000-06-07 | 2003-03-04 | Sterotaxis, Inc. | Guide for medical devices |
US6510347B2 (en) * | 2000-08-17 | 2003-01-21 | William N. Borkan | Spinal cord stimulation leads |
US6832115B2 (en) * | 2000-08-17 | 2004-12-14 | William N. Borkan | Catheter leads for the intrathecal space and method of use |
US6887229B1 (en) * | 2000-11-07 | 2005-05-03 | Pressure Products Medical Supplies Inc. | Method and apparatus for insertion of elongate instruments within a body cavity |
US6629990B2 (en) * | 2001-07-13 | 2003-10-07 | Ad-Tech Medical Instrument Corp. | Heat-removal method and apparatus for treatment of movement disorder episodes |
US6656152B2 (en) * | 2001-11-16 | 2003-12-02 | Ad-Tech Medical Instrument Corp. | Drug delivery catheter assembly with inflatable balloon |
US6773447B2 (en) * | 2002-07-02 | 2004-08-10 | Sentient Engineering & Technology, Llc | Balloon catheter and treatment apparatus |
Cited By (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050090801A1 (en) * | 2003-10-27 | 2005-04-28 | Racz N. S. | Safety spinal catheter |
US20080275395A1 (en) * | 2006-12-22 | 2008-11-06 | Innerspace Medical, Inc. | MRI-Compatible Temperature-Sensing Catheter |
US10159599B2 (en) * | 2007-11-13 | 2018-12-25 | Mgd Innovations, Llc | Meibomian gland intraductal diagnostic and treatment methods |
US20100292630A1 (en) * | 2007-11-13 | 2010-11-18 | Maskin Steven L | Meibomian Gland Intraductal Diagnostic and Treatment Methods |
US8202461B2 (en) | 2008-01-14 | 2012-06-19 | Custom Medical Applications, Inc. | Flow elements for use with flexible spinal needles, needle assemblies for manufacture and methods therefor |
US20100331794A1 (en) * | 2008-01-14 | 2010-12-30 | Racz N Sandor | Flow elements for use with flexible spinal needles, needle assemblies and methods thereof |
US8298208B2 (en) | 2008-01-17 | 2012-10-30 | Custom Medical Applications, Inc. | Flow elements for use with flexible spinal needles, needle assemblies and methods therefor |
US8287496B2 (en) | 2008-01-17 | 2012-10-16 | Custom Medical Applications, Inc. | Flow elements for use with flexible spinal needles, needle assemblies and methods therefor |
US20100298785A1 (en) * | 2008-01-17 | 2010-11-25 | Custom Medical Applications, Inc. | Flow elements for use with flexible spinal needles, needle assemblies and methods therefor |
US20090187140A1 (en) * | 2008-01-17 | 2009-07-23 | Custom Medical Applications, Inc. | Flow elements for use with flexible spinal needles, needle assemblies and methods therefor |
US11337630B2 (en) * | 2012-03-16 | 2022-05-24 | Nuvasive, Inc. | Directional dilator for intraoperative monitoring |
US9888859B1 (en) * | 2013-03-14 | 2018-02-13 | Nuvasive, Inc. | Directional dilator for intraoperative monitoring |
US11298043B2 (en) | 2016-08-30 | 2022-04-12 | The Regents Of The University Of California | Methods for biomedical targeting and delivery and devices and systems for practicing the same |
US11298041B2 (en) | 2016-08-30 | 2022-04-12 | The Regents Of The University Of California | Methods for biomedical targeting and delivery and devices and systems for practicing the same |
US10603210B1 (en) | 2017-02-02 | 2020-03-31 | Mgd Innovations, Llc | Meibomian gland probing with blood product injection |
US11497576B2 (en) | 2017-07-17 | 2022-11-15 | Voyager Therapeutics, Inc. | Trajectory array guide system |
Also Published As
Publication number | Publication date |
---|---|
CA2527193C (en) | 2011-09-20 |
EP1622659B1 (en) | 2010-05-19 |
US20040215162A1 (en) | 2004-10-28 |
US7465292B2 (en) | 2008-12-16 |
US20060079857A1 (en) | 2006-04-13 |
US20060129102A1 (en) | 2006-06-15 |
US7322954B2 (en) | 2008-01-29 |
WO2004096314A2 (en) | 2004-11-11 |
EP1622659A2 (en) | 2006-02-08 |
EP1622659A4 (en) | 2008-04-23 |
ATE468148T1 (en) | 2010-06-15 |
US20060079830A1 (en) | 2006-04-13 |
US7608064B2 (en) | 2009-10-27 |
WO2004096314A3 (en) | 2007-06-28 |
CA2527193A1 (en) | 2004-11-11 |
DE602004027234D1 (en) | 2010-07-01 |
US7255686B2 (en) | 2007-08-14 |
US20070191791A1 (en) | 2007-08-16 |
US7241283B2 (en) | 2007-07-10 |
US7972308B2 (en) | 2011-07-05 |
US20070179440A1 (en) | 2007-08-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7608064B2 (en) | Depth probe for intracranial treatment | |
AU2017213481B2 (en) | Catheter with depth electrode for dual-purpose use | |
JP5927176B2 (en) | Device for interacting with neural tissue and methods of making and using it | |
CN102341036B (en) | Method and apparatus for the detection of aberrant neural-electric activity | |
EP2641528B1 (en) | Fluid management catheter | |
US20150045766A1 (en) | Microelectrode-equipped subdural therapeutic agent delivery strip | |
EP3744244A1 (en) | Flexible brain probe over guidewire | |
US20050245944A1 (en) | Apparatus for facilitating delivery of at least one device to a target site in a body | |
CN104605847A (en) | Intracranial deep electrode | |
Metcalfe et al. | Selective Recording of Urinary Bladder Fullness from the Extradural Sacral Roots |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: AD-TECH MEDICAL INSTRUMENT CORPORATION, WISCONSIN Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:PUTZ, MR. DAVID A.;REEL/FRAME:017447/0558 Effective date: 20060406 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |